Primary or secondary plasma cell leukemia
Concurrent symptomatic amyloidosis or plasma cell leukemia
Plasma cell leukemia
Plasma cell leukemia
Plasma cell leukemia (defined by plasma cell >20%, and/or an absolute plasma cell count of >2 x 10e9/L in peripheral blood).
Active or prior plasma cell leukemia (defined as either 20% of peripheral WBC comprised of plasma/CD138+ cells or an absolute count of 2 x 10^9/L).
Concurrent symptomatic amyloidosis or plasma cell leukemia
Patients with a known diagnosis of plasma cell leukemia
Active plasma cell leukemia and/or leukemic manifestations of lymphoma
Patients with Plasma Cell Leukemia
Plasma cell leukemia
Plasma cell leukemia (greater than 2,000 cells/mcL of circulating plasma cells by standard differential)
Plasma cell leukemia
Plasma cell leukemia
Plasma cell leukemia after initial therapy, who achieved at least a partial remission
Active plasma cell leukemia (defined as either 20% of peripheral white blood cells comprised of plasma/CD138+ cells or an absolute plasma cell count of 2 x 10^9/L)
Multiple myeloma specific:\r\n* Active or prior plasma cell leukemia (defined as either 20% of peripheral white blood cell [WBC] comprised of plasma/cluster of differentiation [CD]138+ cells or an absolute count of 2 x 10^9/L)\r\n* Solitary bone or solitary extramedullary plasmacytoma as the only evidence of plasma cell dyscrasia
Plasma cell leukemia
Patients with a known diagnosis of plasma cell leukemia
Patients with non-measurable MM or primary plasma cell leukemia (> 2.0 × 10^9/L circulating plasma cells by standard differential)
Plasma cell leukemia
Patients with plasma cell leukemia who are transplant candidates
Active plasma cell leukemia
Plasma cell leukemia: after induction chemotherapy
Plasma Cell leukemia after initial therapy, who achieved at least a partial remission
Plasma cell leukemia after initial therapy, in patients who have achieved at least a partial remission
Criteria 4 Plasma cell leukemia (> 2.0 x 109/L circulating plasma cells by standard differential)
Plasma cell leukemia
Plasma cell leukemia (plasma cells > 2000/cubic mm)
Known history of primary plasma cell leukemia or evidence of primary or secondary plasma cell leukemia at the time of screening
Plasma cell leukemia defined as peripheral plasma cell count > 2000/cubic millimeter (mm^3)
Plasma cell leukemia
Plasma cell leukemia
Plasma cell leukemia
Diagnosis of plasma cell leukemia
Diagnosis of plasma cell leukemia
Subjects who have plasma cell leukemia or clinically significant amyloidosis
Active plasma cell leukemia
Active plasma cell leukemia
Patient has concurrent symptomatic amyloidosis or plasma cell leukemia
Plasma cell leukemia (> 2.0 × 10^9/L circulating plasma cells by standard differential)
Plasma cell leukemia
Plasma cell leukemia (> 2.0 × 109/L circulating plasma cells by standard differential)
No plasma cell leukemia (> 2.0 × 10^9/L circulating plasma cells by standard differential)
Plasma cell leukemia (> 20% circulating plasma cells) during screening studies
Plasma cell leukemia
Plasma cell leukemia
Subjects with plasma cell leukemia (PCL)
Documented plasma cell leukemia or known amyloidosis. (Plasma cell leukemia is defined as the presence of >20% plasma cells in the peripheral blood and an absolute plasma cell count of ?2000 muL
Plasma cell leukemia at time of study entry.
Active plasma cell leukemia
Patients with plasma cell leukemia
Plasma cell leukemia
Patients with plasma cell leukemia in >= partial remission are eligible
History of amyloid, plasma cell leukemia or CNS involvement.
Plasma cell leukemia
Received Plasma cell directed chemotherapy within 6 months
Plasma cell leukemia
Plasma cell leukemia or circulating plasma cells >= 2 X 10^9/L
Plasma cell leukemia or circulating plasma cells >= 2 × 10^9/L
Plasma cell leukemia (> 2.0 × 10^9/L circulating plasma cells by standard differential)
Plasma cell leukemia
Plasma cell leukemia or circulating plasma cells ? 2 × 10^9/L.
Active plasma cell leukemia
Plasma cell leukemia
Plasma cell leukemia (> 2.0 × 10^9/L circulating plasma cells by standard differential)
Active or prior plasma cell leukemia (defined as either 20% of peripheral WBC comprised of plasma/CD138+ cells or an absolute count of 2 x 10^9/L).
Active plasma cell leukemia.
Diagnosis of plasma cell dyscrasia
Plasma cell leukemia
Plasma cell leukemia
Known history of primary plasma cell leukemia or evidence of primary or secondary plasma cell leukemia at the time of screening
Plasma creatinine =< 1.6
Active plasma cell leukemia.
Concurrent symptomatic amyloidosis or plasma cell leukemia
Plasma cell leukemia (> 2.0 X109/L circulating plasma cells by standard differential).
Multiple myeloma/plasma cell leukemia or B cell acute lymphoblastic leukemia